OXAZEPAM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for oxazepam and what is the scope of patent protection?
Oxazepam
is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Am Therap, Epic Pharma Llc, Ivax Sub Teva Pharms, Mylan, United Res Labs, Watson Labs, Watson Labs Teva, Alpharma Us Pharms, Quantum Pharmics, Parke Davis, and Sun Pharm Industries, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for oxazepam. Four suppliers are listed for this compound.
Summary for OXAZEPAM
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 12 |
NDAs: | 24 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Clinical Trials: | 15 |
Patent Applications: | 6,904 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for OXAZEPAM |
What excipients (inactive ingredients) are in OXAZEPAM? | OXAZEPAM excipients list |
DailyMed Link: | OXAZEPAM at DailyMed |
Recent Clinical Trials for OXAZEPAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assistance Publique - Hôpitaux de Paris | Phase 2 |
Foundation for a Smoke-Free World | Phase 1/Phase 2 |
Embera NeuroTherapeutics, Inc. | Phase 1/Phase 2 |
Pharmacology for OXAZEPAM
Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for OXAZEPAM
Anatomical Therapeutic Chemical (ATC) Classes for OXAZEPAM
US Patents and Regulatory Information for OXAZEPAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Quantum Pharmics | ZAXOPAM | oxazepam | CAPSULE;ORAL | 070641-001 | Mar 1, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071715-001 | Oct 20, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Am Therap | OXAZEPAM | oxazepam | CAPSULE;ORAL | 071956-001 | Mar 3, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXAZEPAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-006 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Alpharma Us Pharms | SERAX | oxazepam | CAPSULE;ORAL | 015539-004 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.